200 related articles for article (PubMed ID: 21737561)
1. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study.
Jenkins CR; Celli B; Anderson JA; Ferguson GT; Jones PW; Vestbo J; Yates JC; Calverley PM
Eur Respir J; 2012 Jan; 39(1):38-45. PubMed ID: 21737561
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
5. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
6. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Seemungal TA; Wilkinson TM; Hurst JR; Perera WR; Sapsford RJ; Wedzicha JA
Am J Respir Crit Care Med; 2008 Dec; 178(11):1139-47. PubMed ID: 18723437
[TBL] [Abstract][Full Text] [Related]
7. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.
Tsimogianni AM; Papiris SA; Kanavaki S; Stathopoulos GT; Sotiropoulou C; Manali ED; Michalopoulou P; Roussos C; Kotanidou A
Respirology; 2009 Nov; 14(8):1114-20. PubMed ID: 19761538
[TBL] [Abstract][Full Text] [Related]
8. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
Fan VS; Ramsey SD; Make BJ; Martinez FJ
COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
[TBL] [Abstract][Full Text] [Related]
9. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
Yetkin O; Gunen H
Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
[TBL] [Abstract][Full Text] [Related]
10. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study.
Suzuki M; Makita H; Ito YM; Nagai K; Konno S; Nishimura M;
Eur Respir J; 2014 May; 43(5):1289-97. PubMed ID: 24232696
[TBL] [Abstract][Full Text] [Related]
12. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
[TBL] [Abstract][Full Text] [Related]
13. High-risk patients following hospitalisation for an acute exacerbation of COPD.
Piquet J; Chavaillon JM; David P; Martin F; Blanchon F; Roche N;
Eur Respir J; 2013 Oct; 42(4):946-55. PubMed ID: 23349446
[TBL] [Abstract][Full Text] [Related]
14. Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD.
Roede BM; Bresser P; Prins JM; Schellevis F; Verheij TJ; Bindels PJ
Eur Respir J; 2009 Feb; 33(2):282-8. PubMed ID: 19047316
[TBL] [Abstract][Full Text] [Related]
15. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
[TBL] [Abstract][Full Text] [Related]
16. Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial.
Ringbæk T; Green A; Laursen LC; Frausing E; Brøndum E; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():1801-8. PubMed ID: 26366072
[TBL] [Abstract][Full Text] [Related]
17. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease.
Ansari K; Keaney N; Taylor I; Burns G; Farrow M
Postgrad Med J; 2012 Jul; 88(1041):372-6. PubMed ID: 22388793
[TBL] [Abstract][Full Text] [Related]
18. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.
Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA
Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395
[TBL] [Abstract][Full Text] [Related]
19. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
Santibáñez M; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; García-Rivero JL
PLoS One; 2016; 11(6):e0158727. PubMed ID: 27362765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
